Clinical Laserthermia Systems
4,35 SEK
+1,05 %
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.
Lue lisääLiikevaihto ja EBIT-%
Liikevaihto milj.
EBIT-% (oik.)
EPS ja Osinko
EPS (oik.)
Osinko %
Pörssikalenteri
Yhtiökokous '26
Osavuosikatsaus Q2'26
Osavuosikatsaus Q3'26
CLS Publishes Interim Report January - March 2026
CLS Receives Largest Purchase Order Worth SEK 23 Million for Prism[®] Business
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.